Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2003
07/24/2003WO2002088310A3 Cobra gene and uses thereof
07/24/2003WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins
07/24/2003WO2002070645A3 Functional surface display of polypeptides
07/24/2003WO2002062846A3 Method and apparatus for the production of antigens and uses thereof
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same
07/24/2003WO2002044355A3 Protozoan expression systems for lysosomal storage disease genes
07/24/2003US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening
07/24/2003US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
07/24/2003US20030139581 Protocadherin materials and methods
07/24/2003US20030139573 Lipid binding protein 3
07/24/2003US20030139572 Novel compounds
07/24/2003US20030139365 Expression and export of angiogenesis inhibitors as immunofusins
07/24/2003US20030139330 Transcription factors containing two potential dna binding motifs
07/24/2003US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030139328 Complexing; modulating biological activation
07/24/2003US20030139327 Nucleic acids, proteins, and antibodies
07/24/2003US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications
07/24/2003US20030138953 Method for the generation of 3' RNA fragments and N-terminally truncated polypeptides
07/24/2003US20030138951 Conversion of liver stem and progenitor cells to pancreatic functional cells
07/24/2003US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents
07/24/2003US20030138937 Genetically engineered escherichia with reduced DNA complement for use as expression vector in efficient production of important cell products such as riboflavin, lysine and glutamic acid; increased homologous recombination
07/24/2003US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening
07/24/2003US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents
07/24/2003US20030138927 Nucleic acid molecules encoding enzymes having fructosyl polymerase activity
07/24/2003US20030138926 Novel polynucleotides and polypeptides encoded thereby
07/24/2003US20030138914 Factor X deletion mutants and analogues thereof
07/24/2003US20030138907 Preparing and recovering a genetically engineered muscle protein by protecting sulfhydryl groups (reaction with sodium tetrathionate) and isolation by anion exchange chromatography and hydrophobic interaction chromatography
07/24/2003US20030138904 Pro-polypeptide membrane protein for stimulating/inhibiting proliferation/differentiation of chrondrocytes and/or endothelial cells; neovascularization; tumor diagnosis
07/24/2003US20030138903 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138902 Pro-polypeptide membrane protein for stimulating/inhibiting proliferation/differentiation of chrondrocytes and/or endothelial cells; neovascularization; tumor diagnosis
07/24/2003US20030138901 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138900 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138898 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138884 APRIL- a novel protein with growth effects
07/24/2003US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138880 Solid-phase synthesis of oligosaccharides and glycopeptides using glycosynthases
07/24/2003US20030138879 Phosphopantetheinyl transferases and uses thereof
07/24/2003US20030138862 Anti-HLA-DR antibodies and the methods of using thereof
07/24/2003US20030138854 Method for determining BAGE expression
07/24/2003US20030138844 Antibodies binding a gamma carboxyglutamic acid displaying epitope
07/24/2003US20030138843 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis
07/24/2003US20030138822 Polynucleotides and polypeptides, materials incorporating them and methods for using them
07/24/2003US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia
07/24/2003US20030138818 G-protein coupled receptors
07/24/2003US20030138807 Nucleotide sequences coding polypeptide associated with biosynthesis of glycans found as free oligosaccharides or bound to glycosphingolipids; treatment and prevention of infections; gene therapy; antiproliferative agents
07/24/2003US20030138782 Computer-directed assembly of a polynucleotide encoding a target polypeptide
07/24/2003US20030138461 Process for the in vitro culture of different stages of tissular parasites
07/24/2003US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome
07/24/2003US20030138440 Multimeric proteins and methods of making and using same
07/24/2003US20030138434 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct
07/24/2003US20030138424 An antibody capable of inhibiting the binding between parathyroid hormone related protein (PTHrP) and a receptor; antagonists; systemic disorders caused by cancer; anorexic agents; anemia, electrolyte imbalance; immunotherapy
07/24/2003US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease
07/24/2003US20030138421 Human Antibodies specific for interleukin 15 (IL-15)
07/24/2003CA2841097A1 Albumin fusion proteins
07/24/2003CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003CA2473434A1 Methods for making polynucleotides and purifying double-stranded polynucleotides
07/24/2003CA2473108A1 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
07/24/2003CA2473039A1 Novel anti-igf-ir antibodies and uses thereof
07/24/2003CA2472579A1 Hiv vaccine and method of use
07/24/2003CA2471702A1 Human monoclonal antibodies against cd30
07/24/2003CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003CA2471363A1 Albumin fusion proteins
07/24/2003CA2469715A1 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
07/24/2003CA2465178A1 Adapter-directed display system
07/24/2003CA2463008A1 Efficient protein expression system
07/23/2003EP1329512A1 Process for producing protein decomposition product
07/23/2003EP1329509A2 Method for generating a subtracted cDNA library and uses of the generated library
07/23/2003EP1329507A1 Artificial protein having potentiated immunogenicity of epitope
07/23/2003EP1329503A1 Sphingolipid ceramide deacylase gene
07/23/2003EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
07/23/2003EP1329458A2 Peptides that lower blood glucose levels
07/23/2003EP1329223A1 Expression potentiator for protein synthesis regulatory gene
07/23/2003EP1328661A2 Estrogen receptor alpha variants and methods of detection thereof
07/23/2003EP1328653A2 Highly expressible genes
07/23/2003EP1328643A2 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328630A2 Secreted proteins
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328619A1 Human tuberoinfundibular peptide of 39 residues
07/23/2003EP1328547A1 Identification and modification of immunodominant epitopes in polypeptides
07/23/2003EP1328542A1 Von willebrand factor-binding proteins from staphylococci
07/23/2003EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
07/23/2003EP1144587B1 Device for carrying out the cell-free synthesis of proteins
07/23/2003EP1029040B1 Method of increasing efficiency of directed evolution of a gene using phagemid
07/23/2003EP0871665B1 Insulin derivatives
07/23/2003EP0814827B1 Vascular endothelial growth factor-b
07/23/2003EP0756630B1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
07/23/2003EP0743958B1 Avidin-biotin immunoconjugates
07/23/2003EP0714408B1 Tryptase inhibitor
1 ... 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 ... 1125